Pricing Guide

Ozempic Cost

Affordable GLP-1 weight loss medication starting at $199/mo. Licensed providers, free shipping.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Ozempic Cost is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated June 2026Medically reviewed by licensed providers

Ozempic Cost: Weight Method offers compounded GLP-1 treatment starting at $199/month. Compounded semaglutide from $199/month and tirzepatide from $329/month, prescribed by licensed providers. Includes virtual medical consultation and free direct shipping.

Key Fact

Weight Method's compounded semaglutide program for weight management is $154/month, all-inclusive — medication, licensed provider oversight, dosage management, and home delivery, no insurance required. Weight Method does not dispense brand-name Ozempic®. Compounded semaglutide is not FDA-approved.

Source: Weight Method pricing, February 2026

How much does treatment cost per month?

Ozempic's pricing at a retail pharmacy reflects Novo Nordisk's patent-protected market position. List prices vary by dose, and generic semaglutide is not yet available at retail pharmacies. For patients with diabetes coverage, Ozempic may fall on a preferred brand or specialty tier with a copay. However, when prescribed off-label for weight loss, most insurers will deny the claim entirely, leaving the patient responsible for the full retail price. Pharmacy discount programs (GoodRx, RxSaver) can reduce cash prices somewhat, but it is still prohibitively expensive for most households. Weight Method's $154/month compounded semaglutide pricing is a flat all-inclusive monthly fee for compounded semaglutide dispensed by U.S.-licensed 503A pharmacies. Compounded medications are not FDA-approved.

How can you save on treatment?

Weight Method's compounded semaglutide program totals $1,848/year as a flat all-inclusive fee. Brand-name Ozempic purchased cash-pay at a retail pharmacy accumulates a much larger annual cash outlay set by the manufacturer, and that figure shifts with insurance decisions and formulary changes; Weight Method's pricing does not. For patients currently filling Ozempic at a pharmacy for weight management, the conversation is between continuing with the FDA-approved brand (with FDA review behind it), or switching to compounded semaglutide (not FDA-approved) at Weight Method's flat rate. Your provider can discuss the tradeoffs based on your clinical profile, prior medication response, and individual goals. The non-financial considerations matter too. Patients on the conventional pathway can spend weeks navigating prior authorization. Weight Method patients typically begin treatment within days of their initial evaluation.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Brand-name Ozempic purchased cash-pay at a retail pharmacy is set by the manufacturer and is among the most expensive prescriptions to fill without coverage. Weight Method's compounded semaglutide program for weight management is $154/month, all-inclusive, with no insurance required. Compounded semaglutide is not FDA-approved.

No. Ozempic® is a brand-name FDA-approved medication manufactured by Novo Nordisk for type 2 diabetes. Weight Method does not dispense or prescribe brand-name Ozempic. Our prescribing providers issue patient-specific prescriptions for compounded semaglutide, which is prepared by U.S.-licensed 503A compounding pharmacies. Compounded semaglutide is not FDA-approved and has not been reviewed by the FDA for safety, efficacy, or manufacturing quality.

Usually not. Ozempic is FDA-approved for type 2 diabetes, not weight loss. Most insurers will deny claims for Ozempic prescribed off-label for weight management.

No. Brand-name Ozempic® is an FDA-approved finished drug manufactured by Novo Nordisk and reviewed by FDA for safety, efficacy, and manufacturing quality. Brand-name semaglutide remains patent-protected and there is no FDA-approved equivalent finished drug at retail pharmacies. Compounded semaglutide is a separate regulatory category: it is prepared by a state-licensed 503A compounding pharmacy pursuant to a patient-specific prescription and has not been reviewed by FDA for safety, efficacy, or manufacturing quality.

That decision is between you and your prescribing provider. Brand-name Ozempic is FDA-approved (for diabetes). Compounded semaglutide is not FDA-approved. Cost, coverage, prior medication response, and clinical goals all factor in. Weight Method's $154/month all-inclusive program is one option among several.

Get GLP-1 at the Best Price

We offer the most affordable GLP-1 treatments. Starting at $199/month.

See Pricing

Free consultation. No commitment.

Other Cost Guides

Ozempic Cost by State